Visual field loss in young children and mentally handicapped adolescents receiving vigabatrin

Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3028-35. doi: 10.1167/iovs.05-0778.

Abstract

Purpose: In adult patients and in children of school age who have been treated with vigabatrin (VGB), persistent visual field defects have been reported as a side effect. To date, it is unknown to what extent VGB causes visual field loss in young children and mentally handicapped adolescents who cannot be tested with conventional perimetric

Methods: The purpose of the present study was to investigate VGB-induced visual field loss in these patients by using a noncommercial arc perimeter and a forced-choice, preferential-looking method. The visual field size was measured in 30 patients aged 1 to 15 years who had epilepsy and who were treated with VGB. The visual field of these patients was compared to the visual field of 70 control subjects.

Results: In eight (27%) patients who had been treated with VGB, the visual field was constricted compared with the visual field of the children belonging to the control group.

Conclusions: Arc perimetry shows that mentally handicapped patients and children younger than 6 years treated with VGB have visual field loss compared with the loss reported in adult patients receiving VGB.

MeSH terms

  • Adolescent
  • Anticonvulsants / adverse effects*
  • Child
  • Child, Preschool
  • Disabled Children*
  • Epilepsy / drug therapy*
  • Female
  • Humans
  • Infant
  • Male
  • Persons with Mental Disabilities*
  • Vigabatrin / adverse effects*
  • Vision Disorders / chemically induced*
  • Visual Field Tests / methods
  • Visual Fields / drug effects*

Substances

  • Anticonvulsants
  • Vigabatrin